BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23251465)

  • 1. Phosphorylation of SET protein at Ser171 by protein kinase D2 diminishes its inhibitory effect on protein phosphatase 2A.
    Irie A; Harada K; Araki N; Nishimura Y
    PLoS One; 2012; 7(12):e51242. PubMed ID: 23251465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells.
    Irie A; Harada K; Tsukamoto H; Kim JR; Araki N; Nishimura Y
    Int Immunol; 2006 Dec; 18(12):1737-47. PubMed ID: 17077180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.
    Arnaud L; Chen S; Liu F; Li B; Khatoon S; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2011 Sep; 585(17):2653-9. PubMed ID: 21806989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis.
    Saddoughi SA; Gencer S; Peterson YK; Ward KE; Mukhopadhyay A; Oaks J; Bielawski J; Szulc ZM; Thomas RJ; Selvam SP; Senkal CE; Garrett-Mayer E; De Palma RM; Fedarovich D; Liu A; Habib AA; Stahelin RV; Perrotti D; Ogretmen B
    EMBO Mol Med; 2013 Jan; 5(1):105-21. PubMed ID: 23180565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A.
    Christensen DJ; Ohkubo N; Oddo J; Van Kanegan MJ; Neil J; Li F; Colton CA; Vitek MP
    J Immunol; 2011 Feb; 186(4):2535-42. PubMed ID: 21289314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.
    Richard NP; Pippa R; Cleary MM; Puri A; Tibbitts D; Mahmood S; Christensen DJ; Jeng S; McWeeney S; Look AT; Chang BH; Tyner JW; Vitek MP; Odero MD; Sears R; Agarwal A
    Oncotarget; 2016 Dec; 7(51):84214-84227. PubMed ID: 27705940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases.
    Sturany S; Van Lint J; Muller F; Wilda M; Hameister H; Hocker M; Brey A; Gern U; Vandenheede J; Gress T; Adler G; Seufferlein T
    J Biol Chem; 2001 Feb; 276(5):3310-8. PubMed ID: 11062248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.
    Zonta F; Pagano MA; Trentin L; Tibaldi E; Frezzato F; Trimarco V; Facco M; Zagotto G; Pavan V; Ribaudo G; Bordin L; Semenzato G; Brunati AM
    Blood; 2015 Jun; 125(24):3747-55. PubMed ID: 25931585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
    Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
    Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation.
    Wadzinski BE; Wheat WH; Jaspers S; Peruski LF; Lickteig RL; Johnson GL; Klemm DJ
    Mol Cell Biol; 1993 May; 13(5):2822-34. PubMed ID: 8386317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein phosphatase 2A activity by PI3Kγ regulates β-adrenergic receptor function.
    Vasudevan NT; Mohan ML; Gupta MK; Hussain AK; Naga Prasad SV
    Mol Cell; 2011 Mar; 41(6):636-48. PubMed ID: 21419339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dephosphorylation of Sp1 at Ser-59 by protein phosphatase 2A (PP2A) is required for induction of CYP1A1 transcription after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or omeprazole.
    Shimoyama S; Kasai S; Kahn-Perlès B; Kikuchi H
    Biochim Biophys Acta; 2014 Feb; 1839(2):107-15. PubMed ID: 24382322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma.
    Kobayashi Y; Mercado N; Barnes PJ; Ito K
    PLoS One; 2011; 6(12):e27627. PubMed ID: 22205926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
    Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
    EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
    Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
    Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons.
    Mao L; Yang L; Arora A; Choe ES; Zhang G; Liu Z; Fibuch EE; Wang JQ
    J Biol Chem; 2005 Apr; 280(13):12602-10. PubMed ID: 15661743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor.
    Vera J; Jaumot M; Estanyol JM; Brun S; Agell N; Bachs O
    Oncogene; 2006 Jan; 25(2):260-70. PubMed ID: 16170352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.
    Yu G; Yan T; Feng Y; Liu X; Xia Y; Luo H; Wang JZ; Wang X
    Neurobiol Aging; 2013 Jul; 34(7):1748-58. PubMed ID: 23374587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation.
    Ross JA; Cheng H; Nagy ZS; Frost JA; Kirken RA
    J Biol Chem; 2010 Feb; 285(6):3582-3591. PubMed ID: 19923221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Beclin 1 Protein Phosphorylation and Autophagy by Protein Phosphatase 2A (PP2A) and Death-associated Protein Kinase 3 (DAPK3).
    Fujiwara N; Usui T; Ohama T; Sato K
    J Biol Chem; 2016 May; 291(20):10858-66. PubMed ID: 26994142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.